GLP-1 Receptor Agonist interVentIon for poor responders afTer bariAtric Surgery: The GRAVITAS trial
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GRAVITAS
- 11 Oct 2017 Status changed from active, no longer recruiting to completed.
- 22 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Mar 2016 Accrual to date is 8 % according to United Kingdom Clinical Research Network.